Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Getting the Deal Through - Patents 2012
        2. Surge of Patent Application Final Rejections Provides Unique Opportunity for Patent Precent Making
        3. Mexico issues regulations to approve biologic drugs
        4. Latin America Roundtable
        5. New regulations pending
        6. The International Comparative Guide
        7. Marketing authorization for pharmaceutical
        8. Approval of follow-on biologics in Mexico
        9. Mexican Linkage Gazette April 2011
        10. Patent Prosecution Highway in Mexico
        11. 37 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Recent amendment to the Federal Law for Consumer Protection
        2. Amendments to the Federal Law for Consumer Protection
        3. Mexico issues Personal Data Protection Rules
        4. New Regulations Pending
        5. Marketing authorization for pharmaceutical products to foreign applicants
        6. Data Package Exclusivity (DPE)
        7. Supreme Court upholds the worth of formulation patents
        8. Pharmaceutical trademarks
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Advertising 2009
        11. 4 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Advertising in social media networks
        2. Whither Rental Rights?
        3. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Mexico subscribes Madrid Protocol
      2. Presumed Guilty - How can a law firm help win an Emmy?
      3. New rules came in force to speed timeframes in administrative appeal proceedings
      4. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      5. Olivares & Cia. ranking
      6. Data Package Exclusivity (DPE)
      7. Mr. Sergio Olivares Sr's Passing
      8. Pharma Linkage Regulations Supreme Court Decision
      9. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      10. Mexican Congress amends the Patent Law
      11. 1 more item...
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Copyright Law Articles » A public performance in Mexico

A public performance in Mexico

By Luis C. Schmidt
Partner
Copyright World Issue # 170, May 2007
On 16 April 2007, the Supreme Court of Mexico rendered an important resolution in connection with remuneration rights. The background of which is set against a bill passed by Congress in 2003 which recognized the rights for public performance of works-of-authorship. In essence, the provision states that an author and his/her assignee shall have the right to receive a "royalty" for the public performance or transmission of the work that they have created and the right cannot be renounced. However, the bill-opened questions if the right would be part of the bundle of patrimonial copyright rights or if it would be regarded a sui generis right of economic or other nature.
Groups of users like theatres or broadcasters raised strong objections against the bill since, in their consideration, it had opened a window accruing in favour of authors "and" their assignees, concurrent patrimonial and remuneration rights that they would be entitled to at the same time and consequently, that would allow seeking multiple monetary considerations from users in connection with one single event. The group of users viewed the remuneration right as a repetition of the patrimonial right of public performance and accordingly, as a vehicle that authors and assignees would employ in detriment of their constitutional rights. Likewise, the language that Congress employed was regarded by users as equivocal confusing and unfortunate, since it was used a conjunction "and" to describe that both, authors and assignees, would be owners of the right and since nothing was ever mentioned to define the nature of the remuneration right vis-a-vis existing patrimonial rights.
Accordingly, users brought constitutional actions before the federal courts with the purpose of removing the newly adopted bill from the Copyright Law.

Agreeing to disagree

Some of the actions reached the Supreme Court and were analysed simultaneously by the two chambers that compose the high court. The resolutions resulting from each of the chambers had a contradicting effect. While both agreed that the remuneration right that Congress inserted into the Copyright Law was a right in itself of economic nature, but certainly, different from the patrimonial exclusive right of public performance, they disagreed in the reading of the "no-renounce ability" requirement. The first chamber of the Supreme Court stated that the remuneration right could not be renounced, but could be transferred by a living author to any assignee (i.e. a producer). The second chamber supported the idea that, since the right could not be renounced, it could only be transferred from a diseased author to an heir. It was clear that the first chamber's position was beneficial to the cultural industries, whereas the second chamber was more inclined to the author's interests.
The contradicting judgments of the two chambers were raised for the analysis and discussion of the plenary assembly of the Supreme Court. The purpose of the analysis would be holding a session in which the whole issue would be discussed and decided by all Ministers gathered together.
Discussion by the Ministers sitting in the plenary session was a remarkable event. It was the first time in many years that the Supreme Court of Mexico would address copyright questions that required a thorough analysis of the subject's fundaments and principles. The challenge for the Supreme Court would not only rest in defining whether Mexican Copyright Law had introduced non-exclusive remuneration rights adjacent to the exclusive patrimonial rights system or if the newly created right could be waived or if on the contrary authors could not renounce to it. The policy aspects behind the technical considerations were well beyond in terms of importance. Would this resolution be another proof that Mexico has been slowly departing from strict author's rights notions, following NAFTA and other international trends putting rights of authors and users in balance and harmony? Or on the contrary, would the Supreme Court undertake a more protective approach by enhancing the rights of the flesh and bone author, without viewing other interests?

Five-to-four vote

The outcome was ultimately based on the proposal by the first chamber with certain minor modifications. A divided plenary court, giving a five-to-four vote, decided to the existence of a remuneration right that authors enjoy for each time that the work that they have authored is publicly performed and that they can transfer to third parties without limitation of any kind. In keeping with this, under Mexican Law it will be possible that producers of audiovisual or musical works own by transfer the remuneration right of authors, granting all rights to the former to benefit from the exploitation of the works and without that authors have a chance to participate in the same.